Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
In oligometastatic castration-resistant prostate cancer, the rationale to use local SBRT is improved disease control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results